DIFFERENTIAL REGULATION OF FIBROBLAST GROWTH FACTOR-3 CONTROLS FGFR1:FGFR3 BALANCE IN CHONDROCYTES AFTER CARTILAGE INJURY

被引：0
|
作者：
Khan, S. N. [1 ]
Chanalaris, A. [1 ]
Vincent, T. L. [1 ]
机构：
[1] Kennedy Inst Rheumatol, Oxford, England
来源：
OSTEOARTHRITIS AND CARTILAGE | 2016年 / 24卷
关键词：
D O I：
10.1016/j.joca.2016.01.269
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
220
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [31] Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix
    Wu, R
    Connolly, D
    Ngelangel, C
    Bosch, FX
    Muñoz, N
    Cho, KR
    ONCOGENE, 2000, 19 (48) : 5543 - 5546
  • [32] Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
    Young Saing Kim
    Kyung Kim
    Ghee-Young Kwon
    Su Jin Lee
    Se Hoon Park
    BMC Urology, 18
  • [33] Overexpression of the Fibroblast Growth Factor Receptor 1 (FGFR1) in a Model of Spinal Cord Injury in Rats
    Haenzi, Barbara
    Gers-Barlag, Katharina
    Akhoundzadeh, Halima
    Hutson, Thomas H.
    Menezes, Sean C.
    Bunge, Mary Bartlett
    Moon, Lawrence D. F.
    PLOS ONE, 2016, 11 (03):
  • [34] Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
    Kim, Young Saing
    Lee, Soon Il
    Park, Se Hoon
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma
    Kim, Young Saing
    Kim, Kyung
    Kwon, Ghee-Young
    Lee, Su Jin
    Park, Se Hoon
    BMC UROLOGY, 2018, 18
  • [36] Differential regulation of FGFR3 by PTPN1 and PTPN2
    St-Germain, Jonathan R.
    Taylor, Paul
    Zhang, Wen
    Li, Zhihua
    Ketela, Troy
    Moffat, Jason
    Neel, Benjamin G.
    Trudel, Suzanne
    Moran, Michael F.
    PROTEOMICS, 2015, 15 (2-3) : 419 - 433
  • [37] NF449 is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells
    Chlebova, Katarina
    Krejci, Pavel
    FASEB JOURNAL, 2010, 24
  • [38] NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells
    Krejci, Pavel
    Murakami, Shunichi
    Prochazkova, Jirina
    Trantirek, Lukas
    Chlebova, Katarina
    Ouyang, Zhufeng
    Aklian, Anie
    Smutny, Jiri
    Bryja, Vitezslav
    Kozubik, Alois
    Wilcox, William R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (27) : 20644 - 20653
  • [39] Investigation into the role of Fibroblast Growth Factor 8 and its receptor, FGFR3, in the murine allantois
    Jin, Dexter X.
    Downs, Karen M.
    DEVELOPMENTAL BIOLOGY, 2009, 331 (02) : 428 - 428
  • [40] Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
    Pouessel, D.
    Neuzillet, Y.
    Mertens, L. S.
    van der Heijden, M. S.
    de Jong, J.
    Sanders, J.
    Peters, D.
    Leroy, K.
    Manceau, A.
    Maille, P.
    Soyeux, P.
    Moktefi, A.
    Semprez, F.
    Vordos, D.
    de la Taille, A.
    Hurst, C. D.
    Tomlinson, D. C.
    Harnden, P.
    Bostrom, P. J.
    Mirtti, T.
    Horenblas, S.
    Loriot, Y.
    Houede, N.
    Chevreau, C.
    Beuzeboc, P.
    Shariat, S. F.
    Sagalowsky, A. I.
    Ashfaq, R.
    Burger, M.
    Jewett, M. A. S.
    Zlotta, A. R.
    Broeks, A.
    Bapat, B.
    Knowles, M. A.
    Lotan, Y.
    van der Kwast, T. H.
    Culine, S.
    Allory, Y.
    van Rhijn, B. W. G.
    ANNALS OF ONCOLOGY, 2016, 27 (07) : 1311 - 1316
12345